Who is the best donor for a related HLA haplotype-mismatched transplant?

Blood

Volumn 124, Issue 6, 2014, Pages 843-850

  Wang, Yu ^a   Chang, Ying Jun ^a   Xu, Lan Ping ^a   Liu, Kai Yan ^a   Liu, Dai Hong ^a   Zhang, Xiao Hui ^a   Chen, Huan ^a   Han, Wei ^a   Chen, Yu Hong ^a   Wang, Feng Rong ^a   Wang, Jing Zhi ^a   Chen, Yao ^a   Yan, Chen Hua ^a   Huo, Ming Rui ^a   Li, Dan ^a   Huang, Xiao Jun ^a,b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; DONOR; DONOR SELECTION; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGENY; PROGRESSION FREE SURVIVAL; SIBLING; SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KAPLAN MEIER METHOD; LIVING DONOR; MIDDLE AGED; MORTALITY; PARENT; TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; DONOR SELECTION; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVING DONORS; MALE; MIDDLE AGED; PARENTS; SIBLINGS; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905725904     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-563130     Document Type: Article

References (30)

1. Chang YJ, Huang XJ. Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts. Curr Opin Hematol. 2012;19(6):454-461.
2. Chang YJ, Huang XJ. Haploidentical bone marrow transplantation without T-cell depletion. Semin Oncol. 2012;39(6):653-663.
3. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 2011;118(23): 6006-6017.
4. Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23(15):3447-3454.
5. Federmann B, Bornhauser M, Meisner C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica. 2012;97(10): 1523-1531.
6. Rossetti M, Gregori S, Roncarolo MG. Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in nä?ve T cells. Eur J Immunol. 2010;40(11):3097-3106.
7. Raiola AM, Dominietto A, Ghiso A, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant. 2013;19(1):117-122.
8. Kasamon YL, Luznik L, Leffell MS, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant. 2010;16(4):482-489.
9. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21(7):1387-1394. (Pubitemid 46965279)
10. Wang Y, Liu DH, Liu KY, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013; 119(5):978-985.
11. Huang XJ, Liu DH, Liu KY, et al. Treatment of acute leukemia with unmanipulated HLAmismatched/ haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant. 2009;15(2):257-265.
12. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001; 98(7):2043-2051.
13. Loren AW, Bunin GR, Boudreau C, et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(7):758-769. (Pubitemid 43899412)
14. Tamaki S, Ichinohe T, Matsuo K, Hamajima N, Hirabayashi N, Dohy H; Japan Society of Hematopoietic Cell Transplantation. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant. 2001; 28(4):375-380. (Pubitemid 32834356)
15. van Rood JJ, Loberiza FR Jr, Zhang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. 2002;99(5):1572-1577. (Pubitemid 34533028)
16. Stern M, Ruggeri L, Mancusi A, et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood. 2008;112(7):2990-2995.
17. Gratwohl A, Stern M, Brand R, et al; European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115(20):4715-4726.
18. Ash RC, Horowitz MM, Gale RP, et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant. 1991;7(6): 443-452.
19. Fuchs EJ. Human leukocyte antigenhaploidentical stem cell transplantation using T-cell-replete bone marrow grafts. Curr Opin Hematol. 2012;19(6):440-447.
20. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273(5271):70-74. (Pubitemid 26255423)
21. Lipschitz DA, Udupa KB, Indelicato SR, Das M. Effect of age on second messenger generation in neutrophils. Blood. 1991;78(5):1347-1354.
22. Randolph SSB, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004; 103(1):347-352. (Pubitemid 38029959)
23. Carlens S, Ringden O, Remberger M, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22(8):755-761. (Pubitemid 28488318)
24. Ciurea SO, Champlin RE. Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies. Biol Blood Marrow Transplant. 2013;19(2):180-184.
25. Bayraktar UD, Ciurea SO. Strategies in haploidentical stem cell transplantation in adults. Turk J Haematol. 2013;30(4):342-350.
26. Polchi P, Lucarelli G, Galimberti M, et al. Haploidentical bone marrow transplantation from mother to child with advanced leukemia. Bone Marrow Transplant. 1995;16(4):529-535.
27. Huang XJ, Zhao XY, Liu DH, Liu KY, Xu LP. Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion. Leukemia. 2007;21(4):848-851.
28. Zhao XY, Chang YJ, Huang XJ. Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences? Biol Blood Marrow Transplant. 2011;17(10): 1436-1442.
29. Claas FH, Gijbels Y, van der Velden-de Munck J, van Rood JJ. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science. 1988;241(4874):1815-1817.
30. Richa EM, Kunnavakkam R, Godley LA, et al. Influence of related donor age on outcomes after peripheral blood stem cell transplantation. Cytotherapy. 2012;14(6):707-715.